BAX
Price
$30.62
Change
-$0.74 (-2.36%)
Updated
Jun 13 closing price
Capitalization
21.77B
39 days until earnings call
STAA
Price
$17.08
Change
-$0.36 (-2.06%)
Updated
Jun 13 closing price
Capitalization
1.91B
52 days until earnings call
Interact to see
Advertisement

BAX vs STAA

Header iconBAX vs STAA Comparison
Open Charts BAX vs STAABanner chart's image
Baxter International
Price$30.62
Change-$0.74 (-2.36%)
Volume$2.89M
Capitalization21.77B
STAAR Surgical
Price$17.08
Change-$0.36 (-2.06%)
Volume$586.03K
Capitalization1.91B
BAX vs STAA Comparison Chart
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. STAA commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and STAA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (BAX: $30.62 vs. STAA: $17.08)
Brand notoriety: BAX and STAA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 71% vs. STAA: 70%
Market capitalization -- BAX: $21.77B vs. STAA: $1.91B
BAX [@Medical Specialties] is valued at $21.77B. STAA’s [@Medical Specialties] market capitalization is $1.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSTAA’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • STAA’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 5 TA indicator(s) are bullish while STAA’s TA Score has 3 bullish TA indicator(s).

  • BAX’s TA Score: 5 bullish, 4 bearish.
  • STAA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BAX is a better buy in the short-term than STAA.

Price Growth

BAX (@Medical Specialties) experienced а +1.19% price change this week, while STAA (@Medical Specialties) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.91%. For the same industry, the average monthly price growth was +1.14%, and the average quarterly price growth was +0.34%.

Reported Earning Dates

BAX is expected to report earnings on Jul 24, 2025.

STAA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.91% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than STAA($1.91B). STAA has higher P/E ratio than BAX: STAA (90.79) vs BAX (85.61). BAX YTD gains are higher at: 6.105 vs. STAA (-29.683). BAX has higher annual earnings (EBITDA): 1.67B vs. STAA (33.2M). BAX has more cash in the bank: 3.19B vs. STAA (221M). STAA has less debt than BAX: STAA (35.8M) vs BAX (14.4B). BAX has higher revenues than STAA: BAX (14.8B) vs STAA (322M).
BAXSTAABAX / STAA
Capitalization21.8B1.91B1,143%
EBITDA1.67B33.2M5,036%
Gain YTD6.105-29.683-21%
P/E Ratio85.6190.7994%
Revenue14.8B322M4,596%
Total Cash3.19B221M1,445%
Total Debt14.4B35.8M40,223%
FUNDAMENTALS RATINGS
BAX vs STAA: Fundamental Ratings
BAX
STAA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
5864
P/E GROWTH RATING
1..100
1389
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for STAA (82). This means that BAX’s stock grew significantly faster than STAA’s over the last 12 months.

BAX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STAA (100). This means that BAX’s stock grew similarly to STAA’s over the last 12 months.

BAX's SMR Rating (92) in the Medical Specialties industry is in the same range as STAA (94). This means that BAX’s stock grew similarly to STAA’s over the last 12 months.

BAX's Price Growth Rating (58) in the Medical Specialties industry is in the same range as STAA (64). This means that BAX’s stock grew similarly to STAA’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for STAA (89). This means that BAX’s stock grew significantly faster than STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSTAA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
47%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
52%
Bullish Trend 28 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOYU6.610.03
+0.46%
DouYu International Holdings Limited
ABEV2.44-0.01
-0.41%
Ambev SA
CVLT184.62-1.47
-0.79%
Commvault Systems
SYRE17.29-0.42
-2.37%
Spyre Therapeutics
FGEN0.26-0.04
-14.46%
FibroGen

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
-2.36%
RVTY - BAX
53%
Loosely correlated
-2.27%
A - BAX
53%
Loosely correlated
-1.54%
MTD - BAX
51%
Loosely correlated
-2.76%
SYK - BAX
51%
Loosely correlated
-0.84%
TMO - BAX
49%
Loosely correlated
-2.93%
More

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with RVTY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-2.06%
RVTY - STAA
40%
Loosely correlated
-2.27%
MTD - STAA
39%
Loosely correlated
-2.76%
A - STAA
38%
Loosely correlated
-1.54%
WAT - STAA
37%
Loosely correlated
-2.08%
BAX - STAA
35%
Loosely correlated
-2.36%
More